New vaccines and their recommendations have added complexity and made it tough to stay current. For patients, the extra costs can be prohibitive. Learn how to stay abreast of the requirements and engage patients on the issue.
1 Sep 2013
The new availability of vaccines has highlighted the challenges of allocation and distribution, which were the focus of a recent forum hosted by ACP and Annals of Internal Medicine.
2 Feb 2021
Clinicians could benefit from an injection technique “tune-up” in needle placement and needle length, an editorial suggested.
23 Jun 2020
Mandated influenza vaccinations for employees of health care facilities are improving safety for vulnerable patients. Properly implementing such rules is the key to a successful outcome.
1 Oct 2015
Vaccination programs focusing on elderly patients may require supplemental strategies focused on vaccinating children and other high-risk populations to effectively reduce morbidity and mortality, the authors wrote.
3 Mar 2020
A recent ACP/Annals of Internal Medicine forum on COVID-19 considered the timing of vaccination, outpatient treatment, and pre-exposure prophylaxis.
1 Oct 2022
COVID-19 pill study; new vaccine recommendation plus data on waning efficacy, low risk of postvaccine myocarditis; updates on experimental treatments
A peer-reviewed study showed molnupiravir reduced hospitalizations and deaths in high-risk patients, the CDC favored mRNA vaccines over J&J's, experts explained potential issues with waning efficacy data, and a study quantified the low risk of myocarditis after vaccination.
21 Dec 2021
Two ACP members toured Customs and Border Protection (CBP) facilities near the Texas/Mexico border to evaluate the processes and environmental conditions affecting human health at the facilities.
1 Jan 2023
Among other news this week, the NIH and the WHO released results from remdesivir trials, more negative findings were published for hydroxychloroquine, and ACP and Annals of Internal Medicine held a vaccine forum featuring Anthony S. Fauci, MD, MACP, and other experts.
20 Oct 2020
A manufacturer-funded trial quantified the effectiveness of nirmatrelvir/ritonavir in outpatients. A retrospective study found veterans had more mental health diagnoses and received more antidepressants, benzodiazepines, and opioids after COVID-19, while two other studies looked at reactions to second and third doses of the vaccines.
22 Feb 2022